Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: Their relations to age and pulse pressure

Hypertension Research

Volumn 25, Issue 6, 2002, Pages 887-892

  Kato, Johji ^a   Kitamura, Kazuo ^a   Uemura, Tomohiko ^a   Kuwasako, Kenji ^a   Kita, Toshihiro ^a   Kangawa, Kenji ^b   Eto, Tanenao ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Adrenomedullin; Age; Atrial natriuretic peptide; Brain natriuretic peptide; Pulse pressure

Indexed keywords

ADRENOMEDULLIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; HORMONE;

ADULT; AGE; AGED; AGING; ARTERY COMPLIANCE; ARTICLE; BLOOD LEVEL; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; GREAT BLOOD VESSEL; HEART FAILURE; HUMAN; HYPERTENSION; JAPAN; MALE; MEDICAL EXAMINATION; MULTIVARIATE ANALYSIS; NATRIURESIS; NORMAL HUMAN; POPULATION RESEARCH; PULSE PRESSURE; RADIOIMMUNOASSAY; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

EID: 0036868104     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.25.887     Document Type: Article

References (27)

1. Kitamura K, Kangawa K, Kawamoto M, et al: Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553-560.
2. Kitamura K, Eto T: Adrenomedullin-physiological regulator of the cardiovascular system or biochemical curiosity? Curr Opin Nephrol Hypertens 1997; 6: 80-87.
3. Eto T, Kitamura K, Kato J: Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases. Clin Exp Pharmacol Physiol 1999; 26: 371-380.
4. Needleman P, Braine EH, Greenwald JE, et al: The biochemical pharmacology of atrial peptides. Annu Rev Pharmacol Toxicol 1989; 29: 23-54.
5. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 1998; 339: 321-328.
6. Kuriyama S, Kobayashi H, Tomonari H, et al: Circulating adrenomedullin in erythropoietin-induced hypertension. Hypertens Res 2000; 23: 427-432.
7. Kitamura K, Ichiki Y, Tanaka M, et al: Immunoreactive adrenomedullin in human plasma. FEBS Lett 1994; 341: 288-290.
8. Kato J, Kitamura K, Matsui E, et al: Plasma adrenomedullin and natriuretic peptides in patients with essential or malignant hypertension. Hypertens Res 1999; 22: 61-65.
9. Yasue H, Yoshimura M, Sumida H, et al: Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.
10. Ohashi M, Fujio N, Nawata H, et al: High plasma concentrations of human atrial natriuretic polypeptide in aged men. J Clin Endocrinol Metab 1987; 64: 81-85.
11. Wallen T, Landahl S, Hedner T, Saito Y, Masuda I, Nakao K: Brain natriuretic peptide in an elderly population. J Intern Med 1997; 242: 307-311.
12. Lunchner A, Burnett JC Jr, Jougasaki M, et al: Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens 2000; 18: 1121-1128.
13. Klein AL, Burstow DJ, Tajik AJ, Zachariah PK, Bailey KR, Seward JB: Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons. Mayo Clin Proc 1994; 69: 212-224.
14. Sayama H, Nakamura Y, Saito N, Kinoshita M, Suda M: Relationship between left ventricular geometry and brain natriuretic peptide levels in elderly subjects. Gerontology 2000; 46: 71-77.
15. Papper S: The effects of age in reducing renal function. Geriatrics 1973; 28: 83-87.
16. Giannessi D, Andreassi MG, Del Ry S, Clerico A, Colombo MG, Dini N: Possibility of age regulation of the natriuretic peptide C-receptor in human platelets. J Endocrinol Invest 2001; 24: 8-16.
17. Sumitomo T, Nishikimi T, Mukai M, et al: Plasma adrenomedullin concentrations and cardiac and arterial hypertrophy in hypertension. Hypertension 1997; 30: 741-745.
18. Kohno M, Hanehira T, Kano H, et al: Plasma adrenomedullin concentrations in essential hypertension. Hypertension 1996; 27: 102-107.
19. Isumi Y, Shoji H, Sugo S, et al: Regulation of adrenomedullin production in rat endothelial cells. Endocrinology 1998; 139: 838-846.
20. Hayashi M, Shimosawa T, Fujita T: Hyperglycemia increases vascular adrenomedullin expression. Biochem Biophys Res Commun 1999; 258: 453-456.
21. Hayashi M, Shimosawa T, Isaka M, Yamada S, Fujita R, Fujita T: Plasma adrenomedullin in diabetes. Lancet 1997; 350: 1449-1450.
22. Smulyan H, Safar ME: The diastolic blood pressure in systolic hypertension. Ann Intern Med 2000; 132: 233-237.
23. Millar JA, Lever AF, Burke V: Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J Hypertens 1999; 17: 1065-1072.
24. Bouthier JD, De Luca N, Safar ME, Simon AC: Cardiac hypertrophy and arterial distensibility in essential hypertension. Am Heart J 1985; 109: 1345-1352.
25. Brahimi M, Dahan M, Dabire H, Levy BI: Impact of pulse pressure on degree of cardiac hypertrophy in patients with chronic uraemia. J Hypertens 2000; 18; 1645-1650.
26. Roman MJ, Ganau A, Saba PS, Pini R, Pickering TG, Devereux RB: Impact of arterial stiffening on left ventricular structure. Hypertension 2000; 36: 489-494.
27. Zakopoulos NA, Lekakis JP, Papamichael CM, et al: Pulse pressure in normotensives: a marker of cardiovascular disease. Am J Hypertens 2001; 14: 195-199.